NORCHOL-131
(131I) IODOMETHYLNORCHOLESTEROL
| Pharmaceutical form | Injection |
| Nuclide | Iodine 131 |
| Half life | 8.02 days |
| Availability | Thursday |
| Ordering deadline | Friday, before 11 a.m. |
| Radioactive concentration | 7.5 - 15 MBq/mL at calibration |
| Calibration | Wednesday 12 a.m. |
| Available quantities | From 37 to 185 MBq per vial at calibration |
| Expiry | 14 days from the manufacturing date |
| Specific activity | 11 - 33 MBq/mg |
| Radiochemical purity | ≥ 95 % |
| Radionuclidic purity | ≥ 99.9 % |
| pH | 3.5 to 7.0 |
| Storage | At - 20°C |
| Indication |
• Diagnostic evaluation of the functional state of adrenal cortical tissue • Differentiation between metastatic disease to the adrenals (“cold area”) and non-malignant adrenal enlargement in cancer patients • Detection of remnants of functioning tissue in hypercortisonism from adrenalectomy, or of ectopic endocrine tissue • Detection and follow-up of euadrenal tumours |
Key features:
Use the link below
for further informations
![[Bullet]](/gfx/template_files/prettyPhoto/dark_rounded/loader.gif) |
EDICIS |
|
NANOCIS |
|
OSTEOCIS |
|
PENTACIS |
|
PHYTACIS |
|
PULMOCIS |
|
RENOCIS |
|
SCINTIMUN |
|
STAMICIS |
|
TECEOS |
|
VASCULOCIS |
|
NORCHOL-131 |
|
SERALB-125 |
|
ANGIOCIS |
|
Production calendar 1.half 2017 |
|